当前位置：
X-MOL 学术
›
J. Infect. Dis.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
A randomized phase 4 study of immunogenicity and safety following monovalent oral type 2 Sabin polio vaccine challenge in IPV-vaccinated children in Lithuania.
The Journal of Infectious Diseases ( IF 5.0 ) Pub Date : 2020-07-04 , DOI: 10.1093/infdis/jiaa390 Ananda S Bandyopadhyay 1 , Chris Gast 2 , Elizabeth B Brickley 3 , Ricardo Rüttimann 4 , Ralf Clemens 5 , M Steven Oberste 6 , William C Weldon 6 , Margaret E Ackerman 7 , Ruth I Connor 8 , Wendy F Wieland-Alter 8 , Peter Wright 8 , Vytautas Usonis 9
The Journal of Infectious Diseases ( IF 5.0 ) Pub Date : 2020-07-04 , DOI: 10.1093/infdis/jiaa390 Ananda S Bandyopadhyay 1 , Chris Gast 2 , Elizabeth B Brickley 3 , Ricardo Rüttimann 4 , Ralf Clemens 5 , M Steven Oberste 6 , William C Weldon 6 , Margaret E Ackerman 7 , Ruth I Connor 8 , Wendy F Wieland-Alter 8 , Peter Wright 8 , Vytautas Usonis 9
Affiliation
Understanding immunogenicity and safety of monovalent type-2 oral polio vaccine (mOPV2) in inactivated polio vaccine (IPV)-immunized children is of major importance to inform global policy to control circulating vaccine-derived poliovirus (cVDPV) outbreaks.
中文翻译：
在立陶宛接受IPV疫苗接种的儿童中，单价口服2型Sabin脊髓灰质炎疫苗攻击后的免疫原性和安全性随机4期研究。
了解灭活脊髓灰质炎疫苗（IPV）的儿童中单价2型口服脊髓灰质炎疫苗（mOPV2）的免疫原性和安全性对于控制全球循环疫苗源性脊髓灰质炎病毒（cVDPV）爆发的全球政策至关重要。
更新日期：2020-07-05
中文翻译：
在立陶宛接受IPV疫苗接种的儿童中，单价口服2型Sabin脊髓灰质炎疫苗攻击后的免疫原性和安全性随机4期研究。
了解灭活脊髓灰质炎疫苗（IPV）的儿童中单价2型口服脊髓灰质炎疫苗（mOPV2）的免疫原性和安全性对于控制全球循环疫苗源性脊髓灰质炎病毒（cVDPV）爆发的全球政策至关重要。
京公网安备 11010802027423号